Emilio A Herrera Selected Research

Emilio A Herrera Research Topics

Disease

40	Hypoxia (Hypoxemia) 05/2022 - 01/2003
5	Fetal Hypoxia 01/2022 - 01/2012
5	Pulmonary Hypertension 01/2018 - 01/2008
4	Pulmonary Arterial Hypertension 01/2022 - 01/2018
4	Fetal Growth Retardation (Intrauterine Growth Retardation) 01/2021 - 08/2015
3	Vascular Remodeling 01/2022 - 02/2008
3	Hypertension (High Blood Pressure) 01/2019 - 02/2010
3	Lung Diseases (Lung Disease) 12/2013 - 02/2010
1	Right Ventricular Hypertrophy 01/2022
1	Jet Lag Syndrome 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Airway Remodeling 01/2022
1	Brain Ischemia (Cerebral Ischemia) 01/2021
1	Ischemic Stroke 01/2021
1	Stroke (Strokes) 01/2021
1	Hypotension (Low Blood Pressure) 10/2020
1	COVID-19 01/2020
1	Inflammation (Inflammations) 03/2019
1	Birth Weight (Birth Weights) 01/2019
1	Hypercholesterolemia 01/2018
1	Aortic Aneurysm (Aneurysm, Aortic) 03/2017
1	Body Weight (Weight, Body) 03/2017
1	Huntington Disease (Huntington's Disease) 01/2016
1	Infarction (Infarctions) 02/2015
1	Seizures (Absence Seizure) 09/2007
1	Bradycardia 09/2005
1	Fetal Weight 11/2002

Drug/Important Bio-Agent (IBA)

15	MelatoninIBA 01/2022 - 08/2014
10	Vasoconstrictor AgentsIBA 01/2021 - 09/2005
9	AntioxidantsIBA 05/2022 - 01/2013
8	Oxygen (Dioxygen)IBA 01/2021 - 01/2003
6	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2018 - 09/2005
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2012
5	Vasodilator Agents (Vasodilators)IBA 01/2021 - 09/2005
4	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2022 - 01/2012
4	Adrenergic Agents (Adrenergic Drugs)IBA 10/2011 - 01/2003
3	Messenger RNA (mRNA)IBA 01/2016 - 02/2008
3	CatecholaminesIBA 08/2015 - 09/2007
3	GlucocorticoidsIBA 12/2013 - 02/2010
2	Surface-Active Agents (Surfactants)IBA 01/2022 - 01/2017
2	CalciumIBA 01/2021 - 01/2018
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 10/2020 - 01/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 02/2014
2	NG-Nitroarginine Methyl Ester (L-NAME)IBA 01/2019 - 09/2005
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2013 - 01/2012
2	Carbon MonoxideIBA 11/2012 - 01/2008
1	ElastinIBA 01/2022
1	CollagenIBA 01/2022
1	EnzymesIBA 01/2022
1	BAY 58-2667IBA 01/2022
1	SodiumIBA 01/2022
1	Soluble Guanylyl CyclaseIBA 01/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2021
1	Neuroprotective AgentsIBA 01/2021
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 10/2020
1	Epinephrine (Adrenaline)FDA LinkGeneric 10/2020
1	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 10/2020
1	ProstaglandinsIBA 03/2019
1	Ethanol (Ethyl Alcohol)IBA 01/2019
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2019
1	Biological ProductsIBA 01/2018
1	MitogensIBA 01/2018
1	Indicators and Reagents (Reagents)IBA 03/2017
1	rho-Associated KinasesIBA 01/2016
1	Pharmaceutical PreparationsIBA 01/2016
1	fasudil (AT 877)IBA 01/2016
1	GasesIBA 12/2015
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 02/2015
1	Lactic Acid (Lactate)FDA LinkGeneric 02/2014
1	Oxidants (Oxidizing Agents)IBA 02/2014
1	Xanthine OxidaseIBA 02/2014
1	Allopurinol (Remid)FDA LinkGeneric 02/2014
1	Uric Acid (Urate)IBA 02/2014
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2013
1	Drinking WaterIBA 01/2013
1	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 11/2012
1	Pravastatin (Pravachol)FDA LinkGeneric 01/2012
1	Sildenafil Citrate (Viagra)FDA Link 02/2008
1	Adenosine Triphosphatases (ATPase)IBA 09/2007
1	Neuropeptide YIBA 09/2007
1	Saline SolutionIBA 09/2005
1	Nitric Oxide Synthase (NO Synthase)IBA 09/2005
1	Adrenergic Antagonists (Antiadrenergic Agents)IBA 01/2003

Therapy/Procedure

2	Therapeutics 12/2013 - 02/2010
1	Oral Administration 10/2021
1	Intravenous Infusions 10/2020
1	Catheters 10/2020
1	Glycemic Control 01/2018
1	Blood Vessel Prosthesis Implantation 03/2017
1	General Anesthesia 11/2002